Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
27 10 2020
Historique:
received: 26 05 2020
accepted: 08 09 2020
entrez: 23 10 2020
pubmed: 24 10 2020
medline: 15 5 2021
Statut: ppublish

Résumé

Blood group O has been associated with an increased bleeding tendency due to lower von Willebrand factor (VWF) and factor VIII (FVIII) levels. We explored whether blood group O is independently associated with bleeding severity in patients with mild-to-moderate bleeding of unknown cause (BUC) in the Vienna Bleeding Biobank cohort. Bleeding severity was recorded with the Vicenza bleeding score (BS). Blood group O was overrepresented in 422 patients with BUC compared with its presence in 23 145 healthy blood donors (47.2% vs 37.6%; odds ratio, 1.48; 95% confidence interval [CI], 1.22-1.79). The BS and the number of bleeding symptoms were significantly higher in patients with blood group O than in patients with non-O after adjustment for VWF and FVIII levels and sex (least-square [LS] means of BSs: 6.2; 95% CI, 5.8-6.6 vs 5.3; 4.9-5.7; and of number of symptoms: LS, 3.5; 95% CI, 3.2-3.7 vs 3.0; 2.8-3.2, respectively). Oral mucosal bleeding was more frequent in those with blood group O than in those with other blood types (group non-O; 26.1% vs 14.3%), independent of sex and VWF and FVIII levels, whereas other bleeding symptoms did not differ. Patients with blood group O had increased clot density in comparison with those with blood group non-O, as determined by rotational thromboelastometry and turbidimetric measurement of plasma clot formation. There were no differences in thrombin generation, clot lysis, or platelet function. Our data indicate that blood group O is a risk factor for increased bleeding and bleeding severity in patients with BUC, independent of VWF and FVIII levels.

Identifiants

pubmed: 33095871
pii: S2473-9529(20)31910-8
doi: 10.1182/bloodadvances.2020002452
pmc: PMC7594405
doi:

Substances chimiques

ABO Blood-Group System 0
von Willebrand Factor 0
Factor VIII 9001-27-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5157-5164

Informations de copyright

© 2020 by The American Society of Hematology.

Références

J Thromb Haemost. 2008 Dec;6(12):2067-74
pubmed: 18826390
Ann Hematol. 2010 Nov;89(11):1147-54
pubmed: 20532885
J Thromb Haemost. 2005 Dec;3(12):2619-26
pubmed: 16359502
Blood. 2019 Mar 21;133(12):1371-1377
pubmed: 30642918
Haemophilia. 2018 May;24(3):405-413
pubmed: 29388750
Thromb Diath Haemorrh. 1963 Jul 15;143:472-4
pubmed: 14081268
Haematologica. 2007 Mar;92(3):357-65
pubmed: 17339185
Sci Rep. 2020 Jul 7;10(1):11180
pubmed: 32636459
Blood. 2016 May 19;127(20):2481-8
pubmed: 26862110
Gut. 1976 Mar;17(3):169-79
pubmed: 1269984
F1000Res. 2018 Jan 23;7:96
pubmed: 29416854
Biophys J. 1992 Jul;63(1):111-28
pubmed: 1420861
Eur J Intern Med. 2020 Aug;78:34-40
pubmed: 32317240
Gut. 1968 Jun;9(3):319-22
pubmed: 5661969
Biopreserv Biobank. 2018 Dec;16(6):477-482
pubmed: 30335475
Transfus Med. 1996 Mar;6(1):51-9
pubmed: 8696448
Semin Thromb Hemost. 2013 Feb;39(1):72-82
pubmed: 23299820
Thromb Haemost. 2008 Jun;99(6):1013-8
pubmed: 18521502
Thromb Haemost. 1991 Feb 12;65(2):196-201
pubmed: 1711246
Int J Mol Sci. 2019 Jun 30;20(13):
pubmed: 31262040
Blood. 1987 Jun;69(6):1691-5
pubmed: 3495304
Rev Med Chil. 1997 Apr;125(4):409-18
pubmed: 9460281
Gut. 1969 Dec;10(12):1029-30
pubmed: 5366238
J Thromb Haemost. 2006 Jun;4(6):1418-20
pubmed: 16706994
J Thromb Haemost. 2019 Feb;17(2):257-270
pubmed: 30562407
Blood. 2013 Mar 7;121(10):1712-9
pubmed: 23305734
Br J Haematol. 2008 Jan;140(2):236-40
pubmed: 18028481
Blood. 2017 Oct 19;130(16):1795-1799
pubmed: 28811305
J Thromb Haemost. 2019 Feb;17(2):271-282
pubmed: 30618125
Scand J Gastroenterol. 1972;7(1):55-63
pubmed: 4536789
Haemophilia. 2018 Nov;24(6):e428-e430
pubmed: 30259602
J Thromb Haemost. 2005 Jan;3(1):183-5
pubmed: 15634288
Clin Chem Lab Med. 2015 Aug;53(9):1425-32
pubmed: 25503670
Am J Dig Dis. 1966 Oct;11(10):790-5
pubmed: 5297149
PLoS One. 2015 Oct 28;10(10):e0141491
pubmed: 26509437
Clin Chem Lab Med. 2014 Sep;52(9):1273-6
pubmed: 24945431

Auteurs

Dino Mehic (D)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Stefanie Hofer (S)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Christof Jungbauer (C)

Austrian Red Cross, Blood Service for Vienna, Lower Austria and Burgenland, Austria; and.

Alexandra Kaider (A)

Center for Medical Statistics, Informatics and Intelligent Systems.

Helmuth Haslacher (H)

Department of Laboratory Medicine.

Ernst Eigenbauer (E)

IT-Systems and Communications.

Judit Rejtő (J)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Dieter Schwartz (D)

Department of Blood Group Serology and Transfusion Medicine, and.

Bernd Jilma (B)

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Cihan Ay (C)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Ingrid Pabinger (I)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Johanna Gebhart (J)

Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH